China Medicine Corporation
CHME · OTC
12/31/2009 | 12/31/2008 | 12/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $3 | $6 | $0 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $22 | $20 | $14 | $7 |
| Inventory | $3 | $5 | $4 | $2 |
| Other Curr. Assets | $3 | $6 | $6 | $4 |
| Total Curr. Assets | $30 | $34 | $29 | $13 |
| Property Plant & Equip (Net) | $12 | $4 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $17 | $1 | $1 | $0 |
| Long-Term Investments | $8 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $6 | $1 | $0 |
| Total NC Assets | $37 | $11 | $3 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $67 | $45 | $33 | $15 |
| Liabilities | – | – | – | – |
| Payables | $1 | $0 | $0 | $0 |
| Short-Term Debt | $10 | $0 | $0 | $0 |
| Tax Payable | $2 | $1 | $0 | $0 |
| Deferred Revenue | $3 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $0 | $1 | $0 |
| Total Curr. Liab. | $14 | $1 | $1 | $1 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $7 | $0 | $0 | $0 |
| Total NC Liab. | $7 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $21 | $1 | $1 | $1 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $23 | $22 | $14 | $8 |
| AOCI | $4 | $4 | $4 | $1 |
| Other Equity | $13 | $13 | $13 | $4 |
| Total Equity | $45 | $43 | $31 | $13 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $1 | $1 | $1 | $1 |
| Total Liab. & Tot. Equity | $67 | $45 | $33 | $15 |
| Net Debt | $9 | -$3 | -$6 | -$0 |